SD HEALTHCARERecent and archived news stories on: Biotechnology, Doctors, Drugs, Health Insurance, HMO's/PPO's, Hospitals, Medical Devices, Nursing...
San Diego’s instrument maker Illumina Inc. has opened a five-story manufacturing facility on its campus, adding to the company’s sizeable footprint in University Town Center.
San Diego medical device maker ResMed Inc. reported a 17 percent boost to its quarterly revenue, beating Wall Street’s expectations and sending the company’s stock soaring nearly 10 percent.
San Diego’s Heron Therapeutics Inc. plans to raise $150 million in a public offering of its common stock.
San Diego biotech AnaptysBio has set the price of its initial public offering, expecting to raise about $60 million from the sale of its common stock.
Local test maker Banyan Biomarkers is partnering with bioMerieux, a French giant in biotechnology, to develop a blood test that would identify traumatic brain injury.
Shares of locally based DexCom Inc. have soared this month following news that patients will have easier access to the medical device maker’s main product.
The Center for Toxicology and Environmental Health, a consulting firm based in Little Rock, Ark., has opened a Southern California office in Carlsbad and has hired a San Diego State University alumnus to run it.
Local cell therapy company Cytori Therapeutics Inc. is acquiring San Antonio-based Azaya Therapeutics for up to $170 million.
MEDICINE: Savings Can Be High, But Physician Networks May Be Limited
Tim Carter, a local benefits consultant at insurance agency Barney & Barney, offers all kinds of health plan options to his clients. But he reserves something special for just the right customers — the ones who are fed up with insurance premium hikes.
Shares of drugmaker aTyr Pharma climbed over 30 percent Wednesday following news that the San Diego firm’s drug should progress quickly through the regulatory process.
Laura Farmer Sherman, president and CEO of Susan G. Komen San Diego, plans to retire at the end of 2017, the organization announced Tuesday.
A prostate cancer treatment center recently opened in La Jolla offering what it touts as a new image-guided treatment with few side effects and a quick recovery time.
Scripps Health is working to widen access to an HMO that now serves only its employees.
Shares of locally-based DexCom Inc. skyrocketed 26 percent January 13 following news that patients will have easier access to the medical device maker’s lead product.
Local biotech Access Biologics has sold a minority stake of the company for $51 million to Barcelona-based pharmaceutical and chemical firm, Grifols.